Dedifferentiation of Low Grade Chondrosarcomas

Overview

Journal Clin Orthop Relat Res

Publisher Wolters Kluwer

Specialty Orthopedics

Date 1977 Jan 1

PMID 837602

Citations 9

Authors

G B McFarland Jr

L M McKinley

R J Reed

Affiliations

Soon will be listed here.

Abstract

In four unusual cases where a low-grade chondrosarcoma suddenly dedifferentiated into a florid, highly-malignant fibrosarcoma, the average survival was 12 months (range 5-18 months). The surgical treatment of chondrosarcoma consists of a primary excisional biopsy, and if dedifferentiation to fibrosarcoma is seen, radical excision and chemotherapy or irradiation or both.

Citing Articles

Retroperitoneal mesenchymal chondrosarcoma mimicking a large retroperitoneal sacral schwannoma.

DAndrea G, Caroli E, Capponi M, Scicchitano F, Osti M, Bellotti C Neurosurg Rev. 2007; 31(2):225-9.

PMID: 17912561 DOI: 10.1007/s10143-007-0106-4.

Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.

Kudo N, Ogose A, Hotta T, Kawashima H, Gu W, Umezu H Virchows Arch. 2007; 451(3):691-9.

PMID: 17653762 DOI: 10.1007/s00428-007-0426-3.

Dedifferentiated chondrosarcoma--a fatal disease.

Bruns J, Fiedler W, Werner M, Delling G J Cancer Res Clin Oncol. 2005; 131(6):333-9.

PMID: 15785935 DOI: 10.1007/s00432-004-0648-6.

Dedifferentiated chondrosarcoma of humerus with giant cell tumor-like features.

Ishida T, Dorfman H, HABERMANN E Skeletal Radiol. 1995; 24(1):76-80.

PMID: 7709264 DOI: 10.1007/BF02425959.

Primary malignant mesenchymoma of bone: case report, literature review, and distinction of this entity from mesenchymal and dedifferentiated chondrosarcoma.

Kessler S, Mirra J, Ishii T, Thompson J, Brien E Skeletal Radiol. 1995; 24(4):291-5.

PMID: 7644944 DOI: 10.1007/BF00198418.